These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2482799)

  • 1. The effect of smoking on caffeine elimination: implications for its use as a semiquantitative test of liver function.
    Murphy TL; McIvor C; Yap A; Cooksley WG; Halliday JW; Powell LW
    Clin Exp Pharmacol Physiol; 1988 Jan; 15(1):9-13. PubMed ID: 2482799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of acute withdrawal from cigarette smoking on indocyanine green and antipyrine clearance.
    Eldon MA; Luecker PW; MacGee J; Ritschel WA
    J Clin Pharmacol; 1987 Mar; 27(3):226-32. PubMed ID: 3680579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism.
    Benowitz NL; Peng M; Jacob P
    Clin Pharmacol Ther; 2003 Nov; 74(5):468-74. PubMed ID: 14586387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipyrine and caffeine dispositions in clinically normal dogs and dogs with progressive liver disease.
    Boothe DM; Cullen JM; Calvin JA; Jenkins WL; Brown SA; Green RA; Corrier DE
    Am J Vet Res; 1994 Feb; 55(2):254-61. PubMed ID: 8172417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of the effect of antipyrine on caffeine kinetics in six healthy volunteer subjects.
    Soto J; Alsar MJ
    J Clin Pharm Ther; 1997 Jun; 22(3):191-5. PubMed ID: 9447474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking.
    Vestal RE; Norris AH; Tobin JD; Cohen BH; Shock NW; Andres R
    Clin Pharmacol Ther; 1975 Oct; 18(4):425-32. PubMed ID: 1164824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of cigarette smoking on antipyrine oxidation versus acetaminophen conjugation.
    Scavone JM; Greenblatt DJ; LeDuc BW; Blyden GT; Luna BG; Harmatz JS
    Pharmacology; 1990; 40(2):77-84. PubMed ID: 2345775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of phenytoin, carbamazepine, and valproic acid on caffeine metabolism.
    Wietholtz H; Zysset T; Kreiten K; Kohl D; Büchsel R; Matern S
    Eur J Clin Pharmacol; 1989; 36(4):401-6. PubMed ID: 2500346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The assessment of liver microsomal oxidative capacity via caffeine and antipyrine elimination in patients with chronic active hepatitis: preliminary results].
    Soto Alvarez J; Alsar Ortiz MJ
    An Med Interna; 1992 Nov; 9(11):547-50. PubMed ID: 1467403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theophylline and antipyrine disposition in smoking and non-smoking epileptic subjects.
    Acheson DW; Uden S; Braganza JM; Brown SW; Houston JB
    Br J Clin Pharmacol; 1987 Dec; 24(6):812-5. PubMed ID: 3440101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine pharmacokinetics in obesity and following significant weight reduction.
    Caraco Y; Zylber-Katz E; Berry EM; Levy M
    Int J Obes Relat Metab Disord; 1995 Apr; 19(4):234-9. PubMed ID: 7627246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination.
    Wood AJ; Vestal RE; Wilkinson GR; Branch RA; Shand DG
    Clin Pharmacol Ther; 1979 Jul; 26(1):16-20. PubMed ID: 445957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of alcohol and caffeine consumption on caffeine elimination.
    George J; Murphy T; Roberts R; Cooksley WG; Halliday JW; Powell LW
    Clin Exp Pharmacol Physiol; 1986 Oct; 13(10):731-6. PubMed ID: 3802578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipyrine pharmacokinetics in women receiving conjugated estrogens.
    Scavone JM; Greenblatt DJ; Blyden GT
    J Clin Pharmacol; 1988 May; 28(5):463-6. PubMed ID: 3392245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolism.
    Caraco Y; Zylber-Katz E; Berry EM; Levy M
    Eur J Clin Pharmacol; 1995; 47(6):525-30. PubMed ID: 7768256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of age and consumption of tobacco, alcohol and caffeine on antipyrine clearance.
    Loft S; Døssing M; Poulsen HE
    Hum Toxicol; 1988 May; 7(3):277-80. PubMed ID: 3391626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of caffeine elimination and Child's classification in liver cirrhosis.
    Holstege A; Staiger M; Haag K; Gerok W
    Klin Wochenschr; 1989 Jan; 67(1):6-15. PubMed ID: 2921843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine clearance test: a quantitative liver function assessment in patients with liver cirrhosis.
    Shyu JK; Wang YJ; Lee SD; Lu RH; Lo KJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 May; 57(5):329-34. PubMed ID: 8768380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of smoking on caffeine elimination by the liver in patients with chronic liver diseases].
    Hartleb M; Nowak A; Becker A; Mańczyk I
    Pol Arch Med Wewn; 1990 Dec; 84(6):351-6. PubMed ID: 2092323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of physical exercise on one-sample antipyrine clearance.
    Fabbri A; Bianchi G; Zoli M; Marchi E; Marchesini G
    Ital J Gastroenterol; 1991 Feb; 23(2):74-6. PubMed ID: 1747507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.